Eton Pharmaceuticals (ETON) Intangibles (2019 - 2026)

Eton Pharmaceuticals has disclosed Intangibles across 8 years of filings, most recently posting $54.5 million for Q2 2026.

• In Q2 2026, Intangibles rose 65.87% year-over-year to $54.5 million; the TTM figure through Jun 2026 stood at $54.5 million (up 65.87% YoY), while the FY2025 annual figure was $37.3 million, changed 0.0% from the prior year.
• Intangibles came in at $54.5 million for Q2 2026 at Eton Pharmaceuticals, up from $37.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $54.5 million in Q2 2026 to a low of $3.1 million in Q2 2022.
• Average Intangibles over 5 years is $16.5 million, with a median of $5.9 million recorded in 2024.
• Year-over-year, Intangibles surged 974.08% in 2022 and fell 15.34% in 2023.
• Over 5 years, Intangibles stood at $4.8 million in 2022, then fell by 0.32% to $4.7 million in 2023, then surged by 686.28% to $37.3 million in 2024, then changed by 0.0% to $37.3 million in 2025, then soared by 46.36% to $54.5 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $54.5 million in Q2 2026, $37.3 million in Q4 2025, and $31.9 million in Q3 2025.